Kim Francis Y, Barnes Elizabeth A, Ying Lihua, Chen Chihhsin, Lee Lori, Alvira Cristina M, Cornfield David N
Center for Excellence in Pulmonary Biology, Division of Pulmonary, Asthma and Sleep Medicine, Department of Pediatrics, Stanford University Medical School, Stanford, California.
Center for Excellence in Pulmonary Biology, Division of Pulmonary, Asthma and Sleep Medicine, Department of Pediatrics, Stanford University Medical School, Stanford, California
Am J Physiol Lung Cell Mol Physiol. 2015 Feb 15;308(4):L368-77. doi: 10.1152/ajplung.00253.2014. Epub 2014 Nov 14.
Endothelin-1 (ET-1) increases pulmonary vascular tone through direct effects on pulmonary artery smooth muscle cells (PASMC) via membrane-bound ET-1 receptors. Circulating ET-1 contributes to vascular remodeling by promoting SMC proliferation and migration and inhibiting SMC apoptosis. Although endothelial cells (EC) are the primary source of ET-1, whether ET-1 produced by SMC modulates pulmonary vascular tone is unknown. Using transgenic mice created by crossbreeding SM22α-Cre mice with ET-1(flox/flox) mice to selectively delete ET-1 in SMC, we tested the hypothesis that PASMC ET-1 gene expression modulates the pulmonary vascular response to hypoxia. ET-1 gene deletion and selective activity of SM22α promoter-driven Cre recombinase were confirmed. Functional assays were performed under normoxic (21% O2) or hypoxic (5% O2) conditions using murine PASMC obtained from ET-1(+/+) and ET-1(-/-) mic and in human PASMC (hPASMC) after silencing of ET-1 using siRNA. Under baseline conditions, there was no difference in right ventricular systolic pressure (RVSP) between SM22α-ET-1(-/-) and SM22α-ET-1(+/+) (control) littermates. After exposure to hypoxia (10% O2, 21-24 days), RVSP was and vascular remodeling were less in SM22α-ET-1(-/-) mice compared with control littermates (P < 0.01). Loss of ET-1 decreased PASMC proliferation and migration and increased apoptosis under normoxic and hypoxic conditions. Exposure to selective ET-1 receptor antagonists had no effect on either the hypoxia-induced hPASMC proliferative or migratory response. SMC-specific ET-1 deletion attenuates hypoxia-induced increases in pulmonary vascular tone and structural remodeling. The observation that loss of ET-1 inhibited SMC proliferation, survival, and migration represents evidence that ET-1 derived from SMC plays a previously undescribed role in modulating the response of the pulmonary circulation to hypoxia. Thus PASMC ET-1 may modulate vascular tone independently of ET-1 produced by EC.
内皮素 -1(ET-1)通过膜结合的ET-1受体直接作用于肺动脉平滑肌细胞(PASMC),从而增加肺血管张力。循环中的ET-1通过促进平滑肌细胞增殖和迁移以及抑制平滑肌细胞凋亡,导致血管重塑。尽管内皮细胞(EC)是ET-1的主要来源,但平滑肌细胞产生的ET-1是否调节肺血管张力尚不清楚。我们通过将SM22α-Cre小鼠与ET-1(flox/flox)小鼠杂交产生转基因小鼠,以选择性删除平滑肌细胞中的ET-1,从而检验PASMC中ET-1基因表达调节肺血管对缺氧反应的假设。ET-1基因缺失和SM22α启动子驱动的Cre重组酶的选择性活性得到了证实。在常氧(21% O2)或低氧(5% O2)条件下,使用从ET-1(+/+)和ET-1(-/-)小鼠获得的鼠PASMC以及在使用siRNA沉默ET-1后的人PASMC(hPASMC)进行功能测定。在基线条件下,SM22α-ET-1(-/-)和SM22α-ET-1(+/+)(对照)同窝小鼠的右心室收缩压(RVSP)没有差异。暴露于低氧(10% O2,21 - 24天)后,与对照同窝小鼠相比,SM22α-ET-1(-/-)小鼠的RVSP和血管重塑程度更低(P < 0.01)。在常氧和低氧条件下,ET-1的缺失降低了PASMC的增殖和迁移,并增加了细胞凋亡。暴露于选择性ET-1受体拮抗剂对低氧诱导的hPASMC增殖或迁移反应均无影响。平滑肌细胞特异性ET-1缺失减弱了低氧诱导的肺血管张力增加和结构重塑。ET-1缺失抑制平滑肌细胞增殖、存活和迁移的观察结果表明,平滑肌细胞来源的ET-1在调节肺循环对低氧的反应中发挥了先前未描述的作用。因此,PASMC中的ET-1可能独立于内皮细胞产生的ET-1调节血管张力。